Atorvastatin Calcium
Product Images NDC 68071-4267

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

68071 4267 9

68071 4267 9
This is a description of a medication called Atorvastatin Calcium 40mg being manufactured by NuCare Pharmaceuticals, Inc. The medication comes in a bottle containing 90 tablets and the lot number is 000000. The NDC number is 68071-4267-09 and the manufacturing NDC number is 60505-2580-9. The expiration date of the medication is 00-00. The medication is meant for prescription-only and the user is advised to keep it out of reach of children and store it at a controlled temperature of 59-86°F. The user is advised to call their doctor in case of any side effects and maybe report any such effects to the FDA at 1-800-FDA-1088.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
The text seems to be a graph displaying the cumulative hazard percentage with a comparison of Atorvastatin and placebo drugs over a period of four years. The hazard ratio for Atorvastatin is 0.53 with a confidence interval of 0.45 to 0.83. However, the graph is not fully decipherable from the given text.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
This text represents the percentage of subjects experiencing E vert after being administered two different dosages of cholesterol-lowering drugs - Horvastatin 10mg and Sorvastatin 80mg. A statistical analysis of the data shows that Horvastatin resulted in a 22% reduction (HR 0.78) in the risk of major cardiovascular events compared to Sorvastatin. The HR value has a confidence interval (CI) of 0.69-0.89 and a P=0.0002 indicating statistical significance. The text also presents a graph showing the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.